loadpatents
Patent applications and USPTO patent grants for COUPA; Sophie.The latest application filed is for "hpk1 inhibitors".
Patent | Date |
---|---|
Hpk1 Inhibitors App 20220177458 - MEVELLEC; Laurence Anne ;   et al. | 2022-06-09 |
Bicyclic Hpk1 Inhibitors App 20220169644 - MEVELLEC; Laurence Anne ;   et al. | 2022-06-02 |
Bicyclic pyridine, pyrazine, and pyrimidine derivatives as PI3K beta inhibitors Grant 10,894,793 - Berthelot , et al. January 19, 2 | 2021-01-19 |
Inhibitors Of The Interaction Between MDM2 And P53 App 20200121667 - Poncelet; Virginie Sophie ;   et al. | 2020-04-23 |
Azabenzimidazole Derivatives As Pi3k Beta Inhibitors App 20190263804 - Pilatte; Isabelle Noelle Constance ;   et al. | 2019-08-29 |
Bicyclic Pyridine, Pyrazine, And Pyrimidine Derivatives As Pi3k Beta Inhibitors App 20190169199 - Berthelot; Didier Jean-Claude ;   et al. | 2019-06-06 |
Heterocyclyl linked imidazopyridazine derivatives as PI3KB inhibitors Grant 10,202,387 - Mevellec , et al. Feb | 2019-02-12 |
Imidazopyridazine derivatives as PI3KB inhibitors Grant 10,087,187 - Mevellec , et al. October 2, 2 | 2018-10-02 |
Inhibitors Of The Interaction Between MDM2 And P53 App 20180263966 - Poncelet; Virginie Sophie ;   et al. | 2018-09-20 |
Heterocyclyl Linked Imidazopyridazine Derivatives As Pi3kb Inhibitors App 20180057496 - Mevellec; Laurence Anne ;   et al. | 2018-03-01 |
Imidazopyridazine Derivatives As Pi3kb Inhibitors App 20180002336 - Mevellec; Laurence Anne ;   et al. | 2018-01-04 |
Inhibitors Of The Interaction Between Mdm2 And P53 App 20170112818 - Poncelet; Virginie Sophie ;   et al. | 2017-04-27 |
Inhibitors of the interaction between MDM2 and P53 Grant 9,573,933 - Poncelet , et al. February 21, 2 | 2017-02-21 |
Diaza-spiro-{4,4}-nonane derivatives as neurokinin (NK.sub.1) antagonists Grant 8,604,200 - Janssens , et al. December 10, 2 | 2013-12-10 |
Substituted oxa-diaza-spiro-[5.5]-undecanone derivatives and their use as neurokinin antagonists Grant 8,138,334 - Jenssens , et al. March 20, 2 | 2012-03-20 |
Substituted Oxa-diaza-spiro-[5.5]-undecanone Derivatives And Their Use As Neurokinin Antagonists App 20100292228 - Jenssens; Frans Eduard ;   et al. | 2010-11-18 |
Inhibitors of the Interaction Between MDM2 and P53 App 20100240637 - Poncelet; Virginie Sophie ;   et al. | 2010-09-23 |
Substituted diaza-spiro-[4.5]-decane derivatives and their use as neurokinin antagonists Grant 7,612,056 - Janssens , et al. November 3, 2 | 2009-11-03 |
Diaza-spiro--nonane derivatives as neurokinin (nk1) antagonists App 20090221641 - Janssens; Frans Eduard ;   et al. | 2009-09-03 |
Substituted diaza-spiro-[5.5]-undecane derivatives and their use as neurokinin antagonists Grant 7,544,694 - Janssens , et al. June 9, 2 | 2009-06-09 |
Substituted Diaza-Spiro-[4.5]-Decane Derivatives and Their Use as Neurokinin Antagonists App 20070254904 - Janssens; Frans Eduard ;   et al. | 2007-11-01 |
Substituted Diaza-Spiro-[5.5]-Undecane Derivaties and Their Use as Neurokinin Antagonists App 20070232636 - Janssens; Frans Eduard ;   et al. | 2007-10-04 |
Metabotropic glutamate receptor antagonists Grant 7,115,630 - Mabire , et al. October 3, 2 | 2006-10-03 |
Metabotropic glutamate receptor antagonists App 20050209273 - Mabire, Dominique Jean-Pierre ;   et al. | 2005-09-22 |
Metabotropic glutamate receptor antagonists App 20040082592 - Mabire, Dominique Jean-Pierre ;   et al. | 2004-04-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.